Search

Krystal Biotech Inc

Geschlossen

BrancheGesundheitswesen

341.66 -2.64

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

336.21

Max

351.1

Schlüsselkennzahlen

By Trading Economics

Einkommen

-1.2M

55M

Verkäufe

2.9M

119M

KGV

Branchendurchschnitt

41.888

55.725

EPS

1.79

Gewinnspanne

45.938

Angestellte

295

EBITDA

2.9M

66M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+15.14% upside

Dividenden

By Acuity

Nächstes Ergebnis

2. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-490M

9.9B

Vorheriger Eröffnungskurs

344.3

Vorheriger Schlusskurs

341.66

Nachrichtenstimmung

By Acuity

29%

71%

54 / 339 Ranking in Healthcare

Krystal Biotech Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. Sept. 2026, 20:02 UTC

Krystal Biotech Inc shares fell sharply, remaining below the 20-day moving average and near the lower end of their one-month range.

22. Sept. 2026, 23:31 UTC

Krystal Biotech Inc is advancing in after-market trading, gaining notably since Tuesday's close and trading well above its 20-day moving average.

21. Sept. 2026, 19:35 UTC

Krystal Biotech Inc shares fell, trading below Friday's close and under its 20-day moving average after pulling back from an earlier session high.

18. Sept. 2026, 20:13 UTC

Krystal Biotech Inc is trading modestly higher in after-market hours, reflecting broader market gains amid rising Treasury yields and mixed economic signals.

15. Sept. 2026, 19:36 UTC

Krystal Biotech Inc shares are lower today, continuing a decline since Monday amid rising treasury yields that are pressuring broader market sentiment.

10. Sept. 2026, 20:07 UTC

Krystal Biotech Inc shares are lower amid a broader market downturn influenced by rising Treasury yields and heightened inflation concerns. No specific company news was identified.

9. Sept. 2026, 20:07 UTC

Krystal Biotech Inc shares are declining, continuing a three-day downward trend amid rising crude oil prices and no specific company news identified.

8. Sept. 2026, 20:07 UTC

News

Krystal Biotech shares are lower as the market declines amid volatility. Odyssean LLC increased its stake by 94%, now holding shares valued at $3.48 million.

4. Sept. 2026, 20:01 UTC

Krystal Biotech Inc shares are lower amid broader market pressures and rising Treasury yields. No specific company news was identified for the decline.

2. Sept. 2026, 19:36 UTC

Krystal Biotech Inc shares are higher today, reaching a session peak before retracing some gains. The stock remains above its 20-day moving average.

1. Sept. 2026, 23:41 UTC

Krystal Biotech Inc shares are lower in after-market hours, declining from earlier highs despite being above the 20-day moving average. No specific news was identified.

31. Aug. 2026, 20:02 UTC

Krystal Biotech Inc's shares are higher today, showing notable intraday volatility and remaining above their 20-day moving average. No specific news was identified.

25. Aug. 2026, 20:07 UTC

Krystal Biotech Inc shares are higher today, benefiting from easing Treasury yields and strong momentum, despite no specific company news driving the move.

24. Aug. 2026, 19:16 UTC

Krystal Biotech Inc's shares are lower today, continuing a decline since Friday. Market focus remains on upcoming economic events amid inflation concerns.

21. Aug. 2026, 21:01 UTC

Krystal Biotech shares are lower in after-market trading, reflecting a modest decline since Friday's close amid limited price fluctuations.

20. Aug. 2026, 21:01 UTC

Krystal Biotech Inc shares are higher in after-market trading, maintaining a position above their 20-day moving average without any specific news to explain the rise.

19. Aug. 2026, 20:02 UTC

Correlated Moves

Shares rise amid positive momentum in biotechnology sector.

14. Aug. 2026, 19:46 UTC

News

RBC Capital initiated coverage on Krystal Biotech with an Outperform rating and a $400 price target, boosting shares higher since Thursday's close.

13. Aug. 2026, 19:46 UTC

Correlated Moves

Krystal Biotech Inc shares are lower, reflecting a broader decline in the biotechnology sector and trading below their 20-day moving average.

12. Aug. 2026, 20:52 UTC

Krystal Biotech Inc shares declined during after-market hours, trading near the lower end of its one-month range and below its 20-day moving average.

11. Aug. 2026, 21:01 UTC

Krystal Biotech Inc. shares rose in after-market trading, reaching a high of 1.23% above Tuesday's close, despite remaining below its 20-day moving average.

7. Aug. 2026, 19:26 UTC

Krystal Biotech Inc shares are higher during Friday's session, reflecting a gain since Thursday's close. No specific news was identified to explain the movement.

6. Aug. 2026, 19:26 UTC

Shares of Krystal Biotech Inc. are lower today, trading near the lower end of their one-month range and below the 20-day moving average.

5. Aug. 2026, 19:52 UTC

Krystal Biotech Inc shares are lower today, breaking a trend of higher closes. Broader market sentiment is cautious following ADP's weak employment report.

4. Aug. 2026, 20:04 UTC

News

Citigroup raised its price target on Krystal Biotech to $386, contributing to upward movement in shares despite earlier session pullbacks.

3. Aug. 2026, 23:06 UTC

Krystal Biotech Inc shares are higher in after-market hours, recovering from an earlier dip. Broader market sentiment improved following stronger-than-expected economic data.

31. Juli 2026, 23:06 UTC

Krystal Biotech Inc is trading lower in after-market hours amid volatility, with no specific news identified to explain the movement.

30. Juli 2026, 19:39 UTC

Krystal Biotech Inc shares are higher today, maintaining gains since Wednesday's close. The stock remains above its 20-day moving average despite a slight pullback.

29. Juli 2026, 20:04 UTC

Krystal Biotech shares are lower amid a broader market decline, influenced by significant drops in major U.S. stocks ahead of the Federal Reserve's announcement.

28. Juli 2026, 20:03 UTC

Event
Social Media

Krystal Biotech Inc. shares rise amid strong Biotechnology sector gains and positive social media discussions, with Q2 FY2026 earnings expected on August 3.

Peer-Vergleich

Kursveränderung

Krystal Biotech Inc Prognose

Kursziel

By TipRanks

15.14% Vorteil

12-Monats-Prognose

Durchschnitt 404 USD  15.14%

Hoch 474 USD

Tief 361 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Krystal Biotech Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

7

Buy

1

Halten

0

Sell

Stimmung

By Acuity

54 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Krystal Biotech Inc

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.